Published in J Cell Biol on June 01, 1983
Induction of muscle genes in neural cells. J Cell Biol (1984) 1.36
Approximately 1 kilobase of sequence 5' to the two myosin light-chain 1f/3f gene cap sites is sufficient for differentiation-dependent expression. Mol Cell Biol (1988) 1.03
The amplified expression of factors regulating myogenesis in L6 myoblasts. J Cell Biol (1985) 0.80
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Production of bacteriophage mutants by a disturbance of deoxyribonucleic acid metabolism. Nature (1956) 11.27
Effects of cytochalasins on mammalian cells. Nature (1967) 9.98
Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys (1973) 7.81
Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc Natl Acad Sci U S A (1968) 6.29
Acetylcholine receptor turnover in membranes of developing muscle fibers. J Cell Biol (1975) 4.02
The loss of phenotypic traits by differentiated cells, V. The effect of 5-bromodeoxyuridine on cloned chondrocytes. Proc Natl Acad Sci U S A (1968) 3.60
5-BROMODEOXYURIDINE: EFFECT ON MYOGENESIS IN VITRO. Science (1964) 2.99
Inhibition of myoblast fusion after one round of DNA synthesis in 5-bromodeoxyuridine. J Cell Biol (1970) 2.84
Toward molecular mechanisms of developmental processes. Annu Rev Biochem (1973) 2.66
Suppression of malignancy and differentiation in melanotic melanoma cells. Proc Natl Acad Sci U S A (1970) 2.44
Identification of a novel form of myosin light chain present in embryonic muscle tissue and cultured muscle cells. J Mol Biol (1978) 2.03
5-bromodeoxyuridine-induced differentiation of a neuroblastoma. Proc Natl Acad Sci U S A (1970) 1.86
Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell (1974) 1.65
Lac repressor binding to operator analogues: comparison of poly(d(A-T)), poly(d(A-BrU)), and poly(d(A-U)). Biochem Biophys Res Commun (1971) 1.62
The toxic effect of 5-bromodeoxyuridine on cultured epithelial cells. J Biol Chem (1960) 1.42
The isolation of heterokaryons and hybrids by a selective system using irreversible biochemical inhibitors. Exp Cell Res (1978) 1.25
The use of cytochalasin B to distinguish myoblasts from fibroblasts in cultures of developing chick striated muscle. Proc Natl Acad Sci U S A (1974) 1.18
Insulin stimulates myogenesis in a rat myoblast line. Nature (1974) 1.14
Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by purine deoxyribonucleosides. Somatic Cell Genet (1979) 1.03
The binding of lac repressor and the catabolite gene activator protein to halogen-substituted analogues of poly[d(A-T)]. Biochim Biophys Acta (1976) 1.02
Myosin accumulation in mononucleated cells of chick muscle cultures. Dev Biol (1976) 1.01
Synthesis of rat myosin light chains in heterokaryons formed between undifferentiated rat myoblasts and chick skeletal myocytes. J Cell Biol (1981) 1.00
5-Bromodeoxyuridine inhibition of differentiation. Kinetics of inhibition and reversal in myoblasts. Dev Biol (1974) 1.00
Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the amount of 5-BrdUrd in DNA. Cell (1977) 0.96
Differential sensitivity to 5-bromodeoxyuridine during the S phase of synchronized myogenic cells. Dev Biol (1976) 0.94
Inhibition of myogenesis in a rat myoblast line by 5-bromodeoxyuridine. Nature (1975) 0.87
A modified assay procedure for revealing the M form of creatine kinase in cultured muscle cells. Exp Cell Res (1978) 0.87
The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine. Somatic Cell Genet (1982) 0.86
Recovery of heterokaryons at high cell densities following isolation using irreversible biochemical inhibitors. Somatic Cell Genet (1981) 0.85
Induction of myosin light chain synthesis in heterokaryons between normal diploid cells. In Vitro (1982) 0.84
Inhibition of Friend erythroleukemic cell differentiation by bromodeoxyuridine: correlation with the amount of bromodeoxyuridine in DNA. J Cell Physiol (1980) 0.82
Membrane alterations associated with "transformation" by BUdR in BUdR-dependent cells. Fluorescence Polarization studies with a lipid probe. Exp Cell Res (1978) 0.78
Cell surface changes caused by growth of B16 melanoma cells in bromodeoxyuridine. FEBS Lett (1977) 0.77
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69
A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol (1992) 6.56
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
Positive autoregulation of the myogenic determination gene MyoD1. Cell (1989) 4.28
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet (1999) 4.22
A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res (1991) 4.07
Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta (1991) 3.73
Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature (1989) 3.73
Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev (1999) 3.19
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev (2001) 3.16
Telomere position effect in human cells. Science (2001) 2.61
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci U S A (1999) 2.36
Telomerase and cancer. Hum Mol Genet (2001) 2.28
E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene (1993) 2.25
Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol (2000) 2.15
Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem (2000) 2.14
Telomerase activity in human cancer. Curr Opin Oncol (1996) 2.13
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol (1994) 2.00
Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp Cell Res (1989) 1.96
Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol (1999) 1.96
The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet (2000) 1.93
Regulation of telomerase activity in immortal cell lines. Mol Cell Biol (1996) 1.82
Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res (2001) 1.73
Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang. J Biol Chem (2000) 1.73
Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res (1992) 1.67
Biliary excretion of cephalosporins in rats: influence of molecular weight. Antimicrob Agents Chemother (1980) 1.63
Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. Oncogene (1993) 1.59
Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol (1999) 1.55
Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem Biophys Res Commun (2000) 1.54
Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci U S A (1985) 1.54
Formation of anucleate and multinucleate cells in normal and SV 40 transformed WI-38 by cytochalasin B. Exp Cell Res (1972) 1.50
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia (2001) 1.48
Telomerase immortalization of human myometrial cells. Biol Reprod (2002) 1.48
Increasing trends in the use of breast-conserving surgery in California. Am J Public Health (2000) 1.44
Leukaemia in workers exposed to electrical and magnetic fields. Lancet (1982) 1.43
Telomeres and telomerase: a simple picture becomes complex. Cell (1996) 1.41
Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. Proc Natl Acad Sci U S A (1992) 1.41
Pulmonary effects of exposures in silicon carbide manufacturing. Br J Ind Med (1984) 1.39
Multiple myeloma in cosmetologists. Am J Ind Med (1982) 1.38
Induction of muscle genes in neural cells. J Cell Biol (1984) 1.36
Telomeres and telomerase: implications for cancer and aging. Radiat Res (2001) 1.34
Cephaloglycin and its biologically active metabolite desacetylcephaloglycin. Appl Microbiol (1971) 1.34
Malignant mesothelioma: incidence, asbestos exposure, and reclassification of histopathology. Br J Ind Med (1984) 1.34
Hallmarks of telomeres in ageing research. J Pathol (2007) 1.33
The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res (1993) 1.32
A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res (1999) 1.32
Inhibition of human telomerase activity by peptide nucleic acids. Nat Biotechnol (1996) 1.30
Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci U S A (1997) 1.30
Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J Biol Chem (2001) 1.28
Recent trends in mesothelioma incidence in the United States. Am J Ind Med (1986) 1.28
Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol (1997) 1.25
Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun (1999) 1.25
The isolation of heterokaryons and hybrids by a selective system using irreversible biochemical inhibitors. Exp Cell Res (1978) 1.25
Expression of differentiated functions in heterokaryons between skeletal myocytes, adrenal cells, fibroblasts and glial cells. Exp Cell Res (1984) 1.24
Breast cancer stage at diagnosis in relation to duration of medicaid enrollment. Med Care (2001) 1.23
Is telomerase a viable target in cancer? Mutat Res (2011) 1.23
Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Mol Cell Biol (2000) 1.22
Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene (2001) 1.18
Telomerase inhibitors. Trends Biotechnol (2001) 1.18
Use of reiterative selection for defining protein-nucleic acid interactions. Curr Opin Biotechnol (1995) 1.17
Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res (1996) 1.17
Organic chemicals and malignant melanoma. Am J Ind Med (1983) 1.17
Recall of childhood neglect and physical abuse as differential predictors of current psychological functioning. Child Abuse Negl (1996) 1.17
Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J Biol Chem (1997) 1.16
Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene (1993) 1.16
Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol (1996) 1.14
The suppression of myogenic functions in heterokaryons formed by fusing chick myocytes to diploid rat fibroblasts. Cell Differ (1983) 1.13
Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol (1997) 1.13
The reactivation of telomerase activity in cancer progression. Trends Genet (1996) 1.13
Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol (1996) 1.09
MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites. J Cell Biol (1992) 1.06
Pancreas cancer is unrelated to the workplace in Los Angeles. Am J Ind Med (1985) 1.05
Respiratory disease in Utah coal miners. Am Rev Respir Dis (1981) 1.05
Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny. Oncogene (1996) 1.04
The orientation of rhodopsin and other pigments in dry films. J Gen Physiol (1972) 1.02
The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone (1988) 1.02
Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control (1999) 1.01
Synthesis of rat myosin light chains in heterokaryons formed between undifferentiated rat myoblasts and chick skeletal myocytes. J Cell Biol (1981) 1.00
Multiple pathways for the regulation of telomerase activity. Eur J Cancer (1997) 0.98
Respiratory effects of borax dust. Br J Ind Med (1985) 0.97
Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site. Oncogene (1992) 0.97
Characterisation of telomerase immortalised normal human oesophageal squamous cells. Gut (2003) 0.96
Expression of the RNA component of telomerase during human development and differentiation. Cell Growth Differ (1998) 0.96
Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res (1997) 0.96
Molecular biology of myogenic regulatory factors. Mol Biol Med (1991) 0.95
Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985. Br J Cancer (1989) 0.95
Alveolar bone necrosis and tooth loss. a rare complication associated with herpes zoster infection of the fifth cranial nerve. Oral Surg Oral Med Oral Pathol (1983) 0.94
Alternative multimeric structures affect myogenin DNA binding activity. J Biol Chem (1992) 0.94
Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry (1997) 0.94
Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer (1999) 0.94
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo. RNA (2001) 0.94
Aging. When do telomeres matter? Science (2001) 0.94
Ageing and cancer: the telomere and telomerase connection. Novartis Found Symp (2001) 0.94
Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells. J Natl Cancer Inst (2001) 0.93
Re-expression of senescent markers in deinduced reversibly immortalized cells. Exp Gerontol (1992) 0.93
Control of differentiation in heterokaryons and hybrids involving differentiation-defective myoblast variants. J Cell Biol (1984) 0.93
Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control (2001) 0.93